(1-Indanone)-(1,2,3,6-tetrahydropyridine) compounds
US7378425B2 · kind B2 · utility
6Cited by
1References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 15, 2004 |
| Grant date | May 27, 2008 |
| Priority date | — |
| Expiry date | Mar 14, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D211/70
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides an excellent sigma receptor binding agent and/or acetylcholinesterase inhibitor containing an (1-indanone)-(1,2,3,6-tetrahydropyridine) compound. More specifically, it provides an (1-indanone)-(1,2,3,6-tetrahydropyridine) compound represented by the following formula, a pharmacologically acceptable salt thereof or a hydrate thereof:In the formula (I), R1, R2, R3 and R4 are the same as or different from each other.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.